Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (81-90 of 861) with videos related to

Pageof 87
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|November 3, 2014
Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorderKenji Hashimoto
The British Journal of Psychiatry : the Journal of Mental Science|November 5, 2014
BDNF and proBDNF as biomarkers for bipolar disorderKenji Hashimoto
Biological Psychiatry|September 16, 2019
Genomic Triplication of the Glycine Decarboxylase Gene and N-Methyl-D-Aspartate Receptor Hypofunction: Improvement by Glycine and D-CycloserineKenji Hashimoto
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 23, 2014
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major DepressionKenji Hashimoto
Progress in Neurobiology|October 10, 2012
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depressionKenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2024
Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?Kenji Hashimoto
Frontiers in Psychiatry|July 6, 2019
Editorial: Cognitive Enhancement in Psychiatric DisordersTomiki Sumiyoshi, Kenji Hashimoto
Antioxidants & Redox Signaling|August 18, 2010
Magnetic resonance spectroscopy study of the antioxidant defense system in schizophreniaDaisuke Matsuzawa, Kenji Hashimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer]Kenji Hashimoto, Kenji Tamura
Annals of General Psychiatry|April 27, 2010
Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five casesTsutomu Furuse, Kenji Hashimoto
Pageof 87

Showing results (81-90 of 861) with videos related to

Sort By:
Pageof 87
European Archives of Psychiatry and Clinical Neuroscience|November 3, 2014
Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorderKenji Hashimoto
The British Journal of Psychiatry : the Journal of Mental Science|November 5, 2014
BDNF and proBDNF as biomarkers for bipolar disorderKenji Hashimoto
Biological Psychiatry|September 16, 2019
Genomic Triplication of the Glycine Decarboxylase Gene and N-Methyl-D-Aspartate Receptor Hypofunction: Improvement by Glycine and D-CycloserineKenji Hashimoto
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 23, 2014
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major DepressionKenji Hashimoto
Progress in Neurobiology|October 10, 2012
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depressionKenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2024
Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?Kenji Hashimoto
Frontiers in Psychiatry|July 6, 2019
Editorial: Cognitive Enhancement in Psychiatric DisordersTomiki Sumiyoshi, Kenji Hashimoto
Antioxidants & Redox Signaling|August 18, 2010
Magnetic resonance spectroscopy study of the antioxidant defense system in schizophreniaDaisuke Matsuzawa, Kenji Hashimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Breakthrough breast cancer treatment--PARP inhibitor, BRCA, and triple negative breast cancer]Kenji Hashimoto, Kenji Tamura
Annals of General Psychiatry|April 27, 2010
Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five casesTsutomu Furuse, Kenji Hashimoto
Pageof 87